Judge blasts Bio-Rad for using legal privilege as both “sword and shield”

Life sciences company Bio-Rad Laboratories lost a battle to exclude evidence by its former general counsel from a retaliation lawsuit because it used some of the same material during Foreign Corrupt Practices Act presentations to the US Securities and Exchange Commission.

Unlock unlimited access to all Global Investigations Review content